4.7 Editorial Material

Sticky Issues for Adherence in Secondary Prevention

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 70, Issue 13, Pages 1555-1557

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2017.07.788

Keywords

behavioral science; comparative effectiveness; medication adherence; patient engagement; secondary prevention

Funding

  1. National Heart, Lung, and Blood Institute [K01HL133416]
  2. AstraZeneca
  3. Janssen Pharma
  4. Merck Co.
  5. Regeneron Pharm
  6. Genentech
  7. Eli Lilly
  8. Sanofi

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available